Pnc Financial Services Group, Inc. Provention Bio, Inc. Transaction History

Pnc Financial Services Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.7 - $24.21 $8,375 - $30,262	-1,250 Reduced 47.62%	1,375 $33,000
Q4 2022 Feb 10, 2023	BUY	$4.52 - $10.57 $9,040 - $21,140	2,000 Added 320.0%	2,625 $27,000
Q1 2022 May 12, 2022	SELL	$3.4 - $7.88 $238 - $551	-70 Reduced 10.07%	625 $4,000
Q4 2021 Feb 11, 2022	SELL	$5.59 - $7.39 $11,180 - $14,780	-2,000 Reduced 74.21%	695 $3,000
Q3 2021 Nov 05, 2021	SELL	$5.66 - $8.33 $1,069 - $1,574	-189 Reduced 6.55%	2,695 $17,000
Q2 2021 Aug 06, 2021	BUY	$6.71 - $11.04 $4,421 - $7,275	659 Added 29.62%	2,884 $24,000
Q2 2020 Aug 07, 2020	BUY	$7.81 - $17.0 $15,815 - $34,425	2,025 Added 1012.5%	2,225 $31,000
Q1 2020 May 08, 2020	BUY	$5.42 - $17.75 $1,084 - $3,550	200 New	200 $1,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.